A breast biopsy involves removal of a sample of breast tissue or cells to be tested for breast-related disorders (including breast cancer), is usually recommended if an ultrasound, a mammogram, or MRI unveils a region with an uncharacteristic lump in a female breast. This can be performed either surgically or, by a radiologist using a lesser invasive procedure involving some guidance mechanism and a hollow needle. While an image-guided biopsy is done by taking a sample of the tissue from the abnormal area under some guidance (using MRI, ultrasound or mammography), the ultrasound-guided biopsy is done when an ultrasound image is used to guide the radiologist’s instrument to the lumped site. In either case, the therapeutic uses of various biopsy devices are necessary to perform breast biopsies.
Women around the world are increasingly being exposed to toxic chemicals. Increasing global pollution levels as well changing lifestyles of the present day woman are to some extent responsible for it. There are also various types of enhancements that are launched from time to time. While these affirm of no side-effects, sometimes these also lead to the formation of lumps in the female breasts, making it necessary to undergo a breast biopsy to detect the possibility of a breast-related disorder. These and many other factors leading to a rise in the number of breast cancer cases globally. The growing numbers of such cases, as well as a rise in cancer awareness and screening programs, have led to more and more people opting for the use of biopsy device for breast biopsy.
Read the report published by Inkwood Research on “Global Biopsy Device market“
There are various methods in which a breast biopsy can be done. The first one of the lot is Fine Needle Aspiration (or, FNA), in which a very fine needle is used to extract cells or fluid from the lumped area. In the Core Needle (or, CN) technique, a specially tipped needle is employed to remove a sample of the breast tissue, the size of a rice grain. Vacuum-Assisted Devices (VAD) collects tissue samples in a single needle insertion by using a vacuum powered instrument. This instrument can both be ultrasound guided or stereotactically guided. If a needle biopsy doesn’t provide sufficient data, wire localization is done wherein a guide wire placed on the suspicious region helps the surgeon in locating the lesion site for the surgery. An open (surgical) biopsy is then done by making a small cut in the skin and removing a part or the entire lump. Usage wise, the FNA segment is predicted to account for the highest market share presently mainly due to increased demands for minimally invasive procedures. The VAD biopsy segment, on the other hand, is projected to grow at the highest CAGR values due to the lesser-invasive nature of the technique (the procedure involves doing a small cut for inserting the needle, followed by acquiring the sample tissue using a vacuum-powered device). The ultrasound-guided technique is expected to have the highest growth among the various types.
To conclude, there is an increase in the number of breast-related problems in females over the years, and with increasing numbers of such cases and growing awareness among people, the use of biopsy devices for performing breast biopsy is also likely to grow, thus making it an important constituent of the healthcare sector. Some of the key players in the breast biopsy device market are CR Bard, Becton Dickinson, Devicor, and Hologic, among others.
Author: Pratik Patra
Pratik is a Writer, Artist, and Technocrat from India. He is an engineer from IIT Bombay and is currently pursuing his MBA from XIMB.